Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-19-002782

General Counsel and Secretary acquired 117,572 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hadfield Robert General Counsel and Secretary 2019-01-06 Grant or award +117,572 117,572 D
Derivatives
Hadfield Robert General Counsel and Secretary 2019-01-06 Grant or award · Employee Stock Option (right to buy) +185,391 185,391 D
Loading xslF345X03/doc4.xml…